A phase IV, multicentre, open-label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures.

Subjects

Subjects :

Antibodies, Monoclonal, Humanized pharmacology
Antibodies, Monoclonal, Humanized therapeutic use
Factor VIII therapeutic use
Humans
Minor Surgical Procedures
Antibodies, Bispecific pharmacology
Antibodies, Bispecific therapeutic use
Hemophilia A complications
Hemophilia A drug therapy

Details

Language :

English

ISSN :

1365-2516

Volume :

28

Issue :

4

Database :

MEDLINE

Journal :

Haemophilia : the official journal of the World Federation of Hemophilia

Publication Type :

Report

Accession number :

35510949

Full Text :

https://doi.org/10.1111/hae.14574